Works citing this work

3 works

Work: Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

1. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

   Veronika Blum, Beat Müller, Silvia Höfer +7

   ArticleCancer Immunotherapy and BiomarkersEuropean Journal of Dermatology20180 citations

   ABIABI:AkademIndex/openalex/2018.article.000039

2. Translational research of new developments in targeted therapy of colorectal cancer

   Lei Yang, N. E. Atakhanova, Meryelem Tania Churampi Arellano +9

   Review articleColorectal Cancer Treatments and StudiesPathology - Research and Practice20230 citations

   ABIABI:AkademIndex/openalex/2023.review-article.000055

3. Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

   Qamar Abuhassan, Ghaleb Oriquat, R. Roopashree +5

   ArticleInflammasome and immune disordersTissue and Cell20260 citations

   ABIABI:AkademIndex/openalex/2026.article.002974